S'abonner

EVALUATION AND RISK STRATIFICATION OF PATIENTS WITH CHEST PAIN IN THE EMERGENCY DEPARTMENT : Predictors of Life-Threatening Events - 09/09/11

Doi : 10.1016/S0733-8627(05)70015-8 
Robert J. Zalenski, MD, MA a, b, d, Falah Shamsa, PhD a, c, Karla Jayne Pede, BS e
a Department of Emergency Medicine (RJZ, FS) 
b Division of Cardiology, Department of Medicine (RJZ) 
c Center for Healthcare Effectiveness Research (FS), Wayne State University School of Medicine 
d Section of Urgent Care, Department of Medicine (RJZ), John D. Dinghell Veterans Hospital, Detroit, Michigan 
e College of Medicine, University of Saskatchewan, Saskatoon (KJP), Saskatchewan, Canada 

Résumé

While assessing a patient with chest pain consistent with acute myocardial infarction (AMI) or unstable angina, the emergency physician must first estimate the patient's probability of acute cardiac ischemia (ACI), a term that refers collectively to the spectrum of acute ischemic states. This first estimate of the short-term probability of ACI is inferred from the history, physical examination, and electrocardiogram (ECG). In some settings, an initial CK-MB test is also used.23 Patients who meet the physician and hospital's threshold for ACI are further evaluated in the hospital to confirm or exclude this diagnosis, while other life-threatening diagnoses are excluded.64

To manage patients safely, the emergency physician must then make a second, different decision regarding the site of further testing and monitoring. The risk of life-threatening events determines the intensity of monitoring needed during diagnostic testing and thus the site of further medical care. Each of the potentially available choices, the coronary care unit (CCU), the intermediate care unit, the emergency department (ED) chest pain observation unit (CPOU), the hospital ward, or the outpatient setting, has its specific level of intensity, cost, and benefit. Appropriate patient selection requires a second, critical estimate: the probability of a short-term life-threatening event. This probability is the key variable for determining the necessary level of care.8, 18 This estimate must be used to match the availability of intensive, expensive resources appropriately (e.g., one-to-one nursing care) to the patients most likely to need them. Because admission to the CCU is widely viewed as conferring a 15% survival advantage on patients (with cardiac arrest), making the correct decision about disposition is important.56 Figure 1 depicts the pathway the emergency physician should take in making these decisions.

The CCU should be reserved for patients at higher risk for life-threatening events, the intermediate care unit for patients at lower risk for events but at higher probability for ACI;15, 17, 65 the ED CPOU for patients at low risk (for events and ACI (but not low enough to be discharged,17, 46, 63, 65 and a timely community-based evaluation in the outpatient setting, for patients who are at low risk in the short term but at higher risk for cardiac events over the following 1 to 24 months.34, 58

The wide spectrum of settings for the evaluation of ACI has evolved only over the last 10 years. Intermediate care units and ED-based CPOUs are part of these developments and of the trend to increase the specificity of treatment and to decrease hospital use and the cost of care.17, 46, 63, 65 Utilization rates from the Multicenter Chest Pain Study (MCPS) show an astounding reversal of CCU and telemetry use.18 From 1984 to 1986, in a large sample of patients studied with acute chest pain (derivation set), 18% were admitted to intermediate care and 78% to the CCU. In the period from 1990 to 1994, in another set of patients studied (validation set), 84% were admitted to intermediate care and 16% to the CCU.18 During these same two comparison periods, the “rule in” AMI rate for the CCU increased from 31% to 50% and for intermediate care from 4% to 31% (p<0.001).18 The shift away from using intensive settings for monitoring patients is in further evidence in the recommendations made 1994 by the prestigious National Institutes of Health and endorsed by the American College of Emergency Physicians: that low-risk patients with symptoms of unstable angina should be evaluated in the outpatient setting.6

To manage patients safely in this new paradigm, the emergency physician must understand that the risk of complications determines the intensity of monitoring needed during diagnostic testing.6, 18 Appropriately matching a patient's risk to the intensity of service is the solution that reconciles the conflicting priorities with every practicing emergency physician is familiar: minimizing the inappropriate discharge of patients with ACI while maximizing the cost-effectiveness of hospital-based care. Missed AMI is the leading cause of settlement costs because of malpractice in the ED setting48; in addition, the high estimated mortality rate (25%) of the 2% to 4% of patients inappropriately discharged with AMI is cause for concern.37, 42 Perhaps because of this concern there has been an excess of monitoring of chest pain patients in the CCU who are found to be nonischemic and who received no measurable benefit. This has driven the numerous attempts to achieve more cost-effective risk stratification.6, 17, 36, 46, 63 Achieving cost-effectiveness and high sensitivity for ACI, in fact, can occur only by using less expensive settings for the workup of ACI, such as the ED-based CPOU.17, 50 This allows a reduction in the cost of care that partly or wholly offsets the cost of achieving the priority of carefully examining and testing patients who are at low risk of ACI.65

The focus of this article is the prediction of life-threatening events with ED measurements. These events include malignant arrythmias (e.g., ventricular fibrillation, tachycardia, and high-grade atrioventricular [AV] block), pump failure (e.g., cardiogenic shock and congestive heart failure), cardiac arrest, and death. The ED measures include the history, physical examination, ECG, and their combinations. The authors also examine the prognostic value of newer cardiac markers and imaging tests. In a final section, we extend the risk stratification to patients who are at longer-term risk of cardiac death from 1 month to 2 years postdischarge. Such patients are commonly discharged from the ICU.

Le texte complet de cet article est disponible en PDF.

Plan


 Address reprint requests to Robert J. Zalensky, MD, MA, University Health Center, 8D, Wayne State University School of Medicine, 4201 St. Antoine, Detroit, MI 48201


© 1998  W. B. Saunders Company. Publié par Elsevier Masson SAS. Tous droits réservés.© 1996 
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 16 - N° 3

P. 495-517 - août 1998 Retour au numéro
Article précédent Article précédent
  • PREFACE
  • R.K. THAKUR, EARL J. REISDORFF
| Article suivant Article suivant
  • EARLY LABORATORY INDICATORS OF ACUTE MYOCARDIAL INFARCTION
  • Douglas M. Char, Elizabeth Israel, Jack Ladenson

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.